Spinster Homolog 2 () Deficiency Causes Early Onset Progressive Hearing Loss

English version České info

Progressive hearing loss is common in the human population but we know very little about the molecular mechanisms involved. Mutant mice are useful for investigating these mechanisms and have revealed a wide range of different abnormalities that can all lead to the same outcome: deafness. We report here our findings of a new mouse line with a mutation in the Spns2 gene, affecting the release of a lipid called sphingosine-1-phosphate, which has an important role in several processes in the body. For the first time, we report that this molecular pathway is required for normal hearing through a role in generating a voltage difference that acts like a battery, allowing the sensory hair cells of the cochlea to detect sounds at extremely low levels. Without the normal function of the Spns2 gene and release of sphingosine-1-phosphate locally in the inner ear, the voltage in the cochlea declines, leading to rapid loss of sensitivity to sound and ultimately to complete deafness. The human version of this gene, SPNS2, may be involved in human deafness, and understanding the underlying mechanism presents an opportunity to develop potential treatments for this form of hearing loss.

Vyšlo v časopise: Spinster Homolog 2 () Deficiency Causes Early Onset Progressive Hearing Loss. PLoS Genet 10(10): e32767. doi:10.1371/journal.pgen.1004688
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1004688

Souhrn

Zdroje

1. FukuharaS, SimmonsS, KawamuraS, InoueA, OrbaY, et al. (2012) The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. J Clin Invest 122: 1416–1426.

2. MendozaA, BreartB, Ramos-PerezWD, PittLA, GobertM, et al. (2012) The transporter spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate. Cell Rep 2: 1104–1110.

3. HisanoY, KobayashiN, YamaguchiA, NishiT (2012) Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells. PLoS One 7: e38941.

4. NijnikA, ClareS, HaleC, ChenJ, RaisenC, et al. (2012) The role of sphingosine-1-phosphate transporter spns2 in immune system function. J Immunol 189: 102–111.

5. NagahashiM, KimEY, YamadaA, RamachandranS, AllegoodJC, et al. (2012) Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels and the lymphatic network. FASEB J 27: 1001–11.

6. KawaharaA, NishiT, HisanoY, FukuiH, YamaguchiA, et al. (2009) The Sphingolipid Transporter Spns2 Functions in Migration of Zebrafish Myocardial Precursors. Science 323: 524–527.

7. ZhangH, DesaiNN, OliveraA, SekiT, BrookerG, et al. (1991) Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J Cell Biol 114: 155–167.

8. OliveraA, SpiegelS (1993) Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 365: 557–560.

9. CuvillierO, PirianovG, KleuserB, VanekPG, CosoOA, et al. (1996) Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381: 800–803.

10. WangF, Van BrocklynJR, HobsonJP, MovafaghS, Zukowska-GrojecZ, et al. (1999) Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor. Potential involvement in angiogenesis. J Biol Chem 274: 35343–35350.

11. LeeMJ, ThangadaS, ClaffeyKP, AncellinN, LiuCH, et al. (1999) Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99: 301–312.

12. LiuY, WadaR, YamashitaT, MiY, DengCX, et al. (2000) Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 106: 951–961.

13. GarciaJG, LiuF, VerinAD, BirukovaA, DechertMA, et al. (2001) Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest 108: 689–701.

14. KuppermanE, AnS, OsborneN, WaldronS, StainierDY (2000) A sphingosine-1-phosphate receptor regulates cell migration during vertebrate heart development. Nature 406: 192–195.

15. BrinkmannV, DavisMD, HeiseCE, AlbertR, CottensS, et al. (2002) The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J Biol Chem 277: 21453–21457.

16. MandalaS, HajduR, BergstromJ, QuackenbushE, XieJ, et al. (2002) Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296: 346–349.

17. VenkataramanK, LeeYM, MichaudJ, ThangadaS, AiY, et al. (2008) Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res 102: 669–676.

18. PappuR, SchwabSR, CornelissenI, PereiraJP, RegardJB, et al. (2007) Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 316: 295–298.

19. VenkataramanK, ThangadaS, MichaudJ, OoML, AiY, et al. (2006) Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient. Biochem J 397: 461–471.

20. WhiteJK, GerdinAK, KarpNA, RyderE, BuljanM, et al. (2013) Genome-wide Generation and Systematic Phenotyping of Knockout Mice Reveals New Roles for Many Genes. Cell 154: 452–464.

21. SkarnesWC, RosenB, WestAP, KoutsourakisM, BushellW, et al. (2011) A conditional knockout resource for the genome-wide study of mouse gene function. Nature 474: 337–342.

22. SteelKP, BockGR (1983) Cochlear dysfunction in the jerker mouse. Behav Neurosci 97: 381–391.

23. TasakiI, SpyropoulosCS (1959) Stria vascularis as source of endocochlear potential. J Neurophysiol 22: 149–155.

24. SteelKP, BarkwayC (1989) Another role for melanocytes: their importance for normal stria vascularis development in the mammalian inner ear. Development 107: 453–463.

25. AlltG, LawrensonJG (2001) Pericytes: cell biology and pathology. Cells Tissues Organs 169: 1–11.

26. BergersG, SongS (2005) The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 7: 452–464.

27. CableJ, SteelKP (1991) Identification of two types of melanocyte within the stria vascularis of the mouse inner ear. Pigment Cell Res 4: 87–101.

28. JabbaSV, OelkeA, SinghR, MagantiRJ, FlemingS, et al. (2006) Macrophage invasion contributes to degeneration of stria vascularis in Pendred syndrome mouse model. BMC Med 4: 37.

29. ZhangW, DaiM, FridbergerA, HassanA, DegagneJ, et al. (2012) Perivascular-resident macrophage-like melanocytes in the inner ear are essential for the integrity of the intrastrial fluid-blood barrier. Proc Natl Acad Sci U S A 109: 10388–10393.

30. SpicerSS, SchulteBA (1991) Differentiation of inner ear fibrocytes according to their ion transport related activity. Hear Res 56: 53–64.

31. MatsuokaT, AhlbergPE, KessarisN, IannarelliP, DennehyU, et al. (2005) Neural crest origins of the neck and shoulder. Nature 436: 347–355.

32. BassettJH, GogakosA, WhiteJK, EvansH, JacquesRM, et al. (2012) Rapid-throughput skeletal phenotyping of 100 knockout mice identifies 9 new genes that determine bone strength. PLoS Genet 8: e1002858.

33. MattapallilMJ, WawrousekEF, ChanCC, ZhaoH, RoychoudhuryJ, et al. (2012) The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest Ophthalmol Vis Sci 53: 2921–2927.

34. SaltAN, MelicharI, ThalmannR (1987) Mechanisms of endocochlear potential generation by stria vascularis. Laryngoscope 97: 984–991.

35. MinowaO, IkedaK, SugitaniY, OshimaT, NakaiS, et al. (1999) Altered cochlear fibrocytes in a mouse model of DFN3 nonsyndromic deafness. Science 285: 1408–1411.

36. MarcusDC, WuT, WangemannP, KofujiP (2002) KCNJ10 (Kir4.1) potassium channel knockout abolishes endocochlear potential. Am J Physiol Cell Physiol 282: C403–407.

37. WangemannP, ItzaEM, AlbrechtB, WuT, JabbaSV, et al. (2004) Loss of KCNJ10 protein expression abolishes endocochlear potential and causes deafness in Pendred syndrome mouse model. BMC Med 2: 30.

38. RickheitG, MaierH, StrenzkeN, AndreescuCE, De ZeeuwCI, et al. (2008) Endocochlear potential depends on Cl- channels: mechanism underlying deafness in Bartter syndrome IV. Embo J 27: 2907–2917.

39. NorgettEE, GolderZJ, Lorente-CanovasB, InghamN, SteelKP, et al. (2012) Atp6v0a4 knockout mouse is a model of distal renal tubular acidosis with hearing loss, with additional extrarenal phenotype. Proc Natl Acad Sci U S A 109: 13775–13780.

40. KitajiriS, MiyamotoT, MineharuA, SonodaN, FuruseK, et al. (2004) Compartmentalization established by claudin-11-based tight junctions in stria vascularis is required for hearing through generation of endocochlear potential. J Cell Sci 117: 5087–5096.

41. Cohen-SalmonM, OttT, MichelV, HardelinJP, PerfettiniI, et al. (2002) Targeted ablation of connexin26 in the inner ear epithelial gap junction network causes hearing impairment and cell death. Curr Biol 12: 1106–1111.

42. Cohen-SalmonM, RegnaultB, CayetN, CailleD, DemuthK, et al. (2007) Connexin30 deficiency causes instrastrial fluid-blood barrier disruption within the cochlear stria vascularis. Proceedings of the National Academy of Sciences 104: 6229–6234.

43. TeubnerB, MichelV, PeschJ, LautermannJ, Cohen-SalmonM, et al. (2003) Connexin30 (Gjb6)-deficiency causes severe hearing impairment and lack of endocochlear potential. Hum Mol Genet 12: 13–21.

44. OhlemillerKK, RiceME, GagnonPM (2008) Strial microvascular pathology and age-associated endocochlear potential decline in NOD congenic mice. Hear Res 244: 85–97.

45. OhlemillerKK (2009) Mechanisms and genes in human strial presbycusis from animal models. Brain Res 1277: 70–83.

46. LuMH, TakemotoM, WatanabeK, LuoH, NishimuraM, et al. (2012) Deficiency of sphingomyelin synthase-1 but not sphingomyelin synthase-2 causes hearing impairments in mice. J Physiol 590: 4029–4044.

47. MustaphaM, FangQ, GongTW, DolanDF, RaphaelY, et al. (2009) Deafness and permanently reduced potassium channel gene expression and function in hypothyroid Pit1dw mutants. J Neurosci 29: 1212–1223.

48. SchuknechtHF, GacekMR (1993) Cochlear pathology in presbycusis. Ann Otol Rhinol Laryngol 102: 1–16.

49. SteelKP (1995) Inherited hearing defects in mice. Annu Rev Genet 29: 675–701.

50. GowA, DaviesC, SouthwoodCM, FrolenkovG, ChrustowskiM, et al. (2004) Deafness in Claudin 11-null mice reveals the critical contribution of basal cell tight junctions to stria vascularis function. J Neurosci 24: 7051–7062.

51. SteelKP, BarkwayC, BockGR (1987) Strial dysfunction in mice with cochleo-saccular abnormalities. Hear Res 27: 11–26.

52. LevkauB (2008) Sphingosine-1-phosphate in the regulation of vascular tone: a finely tuned integration system of S1P sources, receptors, and vascular responsiveness. Circ Res 103: 231–233.

53. SchererEQ, LidingtonD, OestreicherE, ArnoldW, PohlU, et al. (2006) Sphingosine-1-phosphate modulates spiral modiolar artery tone: A potential role in vascular-based inner ear pathologies? Cardiovasc Res 70: 79–87.

54. KonoM, BelyantsevaIA, SkouraA, FrolenkovGI, StarostMF, et al. (2007) Deafness and stria vascularis defects in S1P2 receptor-null mice. J Biol Chem 282: 10690–10696.

55. CableJ, SteelKP (1998) Combined cochleo-saccular and neuroepithelial abnormalities in the Varitint-waddler-J (VaJ) mouse. Hear Res 123: 125–136.

56. OhlemillerKK, LettJM, GagnonPM (2006) Cellular correlates of age-related endocochlear potential reduction in a mouse model. Hear Res 220: 10–26.

57. CamererE, RegardJB, CornelissenI, SrinivasanY, DuongDN, et al. (2009) Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest 119: 1871–1879.

58. WangL, DudekSM (2009) Regulation of vascular permeability by sphingosine 1-phosphate. Microvasc Res 77: 39–45.

59. McVerryBJ, PengX, HassounPM, SammaniS, SimonBA, et al. (2004) Sphingosine 1-phosphate reduces vascular leak in murine and canine models of acute lung injury. Am J Respir Crit Care Med 170: 987–993.

60. SpicerSS, SchulteBA (2005) Pathologic changes of presbycusis begin in secondary processes and spread to primary processes of strial marginal cells. Hear Res 205: 225–240.

61. OhlemillerKK, RiceME, LettJM, GagnonPM (2009) Absence of strial melanin coincides with age-associated marginal cell loss and endocochlear potential decline. Hear Res 249: 1–14.

62. ChenJ, NathansJ (2007) Estrogen-related receptor beta/NR3B2 controls epithelial cell fate and endolymph production by the stria vascularis. Dev Cell 13: 325–337.

63. LeeJH, KimSJ, JungSJ, LimW, KimKW, et al. (2000) Voltage-dependent K(+) currents in spiral prominence epithelial cells of rat cochlea. Hear Res 146: 7–16.

64. RoyauxIE, BelyantsevaIA, WuT, KacharB, EverettLA, et al. (2003) Localization and functional studies of pendrin in the mouse inner ear provide insight about the etiology of deafness in pendred syndrome. J Assoc Res Otolaryngol 4: 394–404.

65. EverettLA, BelyantsevaIA, Noben-TrauthK, CantosR, ChenA, et al. (2001) Targeted disruption of mouse Pds provides insight about the inner-ear defects encountered in Pendred syndrome. Hum Mol Genet 10: 153–161.

66. SpicerSS, SchulteBA (1996) The fine structure of spiral ligament cells relates to ion return to the stria and varies with place-frequency. Hear Res 100: 80–100.

67. SchulteBA, AdamsJC (1989) Distribution of immunoreactive Na+,K+-ATPase in gerbil cochlea. J Histochem Cytochem 37: 127–134.

68. CrouchJJ, SakaguchiN, LytleC, SchulteBA (1997) Immunohistochemical localization of the Na-K-Cl co-transporter (NKCC1) in the gerbil inner ear. J Histochem Cytochem 45: 773–778.

69. MaceykaM, HarikumarKB, MilstienS, SpiegelS (2012) Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 22: 50–60.

70. AdadaM, CanalsD, HannunYA, ObeidLM (2013) Sphingosine-1-phosphate receptor 2. FEBS J

71. HerrDR, GrilletN, SchwanderM, RiveraR, MullerU, et al. (2007) Sphingosine 1-phosphate (S1P) signaling is required for maintenance of hair cells mainly via activation of S1P2. J Neurosci 27: 1474–1478.

72. MacLennanAJ, BennerSJ, AndringaA, ChavesAH, RosingJL, et al. (2006) The S1P2 sphingosine 1-phosphate receptor is essential for auditory and vestibular function. Hear Res 220: 38–48.

73. IshiiM, KikutaJ, ShimazuY, Meier-SchellersheimM, GermainRN (2010) Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo. J Exp Med 207: 2793–2798.

74. BreuskinI, BodsonM, ThelenN, ThiryM, BorgsL, et al. (2009) Sox10 promotes the survival of cochlear progenitors during the establishment of the organ of Corti. Dev Biol 335: 327–339.

75. WakaokaT, MotohashiT, HayashiH, KuzeB, AokiM, et al. (2013) Tracing Sox10-expressing cells elucidates the dynamic development of the mouse inner ear. Hear Res 302: 17–25.

76. JungB, ObinataH, GalvaniS, MendelsonK, DingBS, et al. (2012) Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development. Dev Cell 23: 600–610.

77. MendelsonK, ZygmuntT, Torres-VazquezJ, EvansT, HlaT (2013) Sphingosine 1-phosphate receptor signaling regulates proper embryonic vascular patterning. J Biol Chem 288: 2143–2156.

78. TestaG, SchaftJ, van der HoevenF, GlaserS, AnastassiadisK, et al. (2004) A reliable lacZ expression reporter cassette for multipurpose, knockout-first alleles. Genesis 38: 151–158.

79. RyderE, GleesonD, SethiD, VyasS, MiklejewskaE, et al. (2013) Molecular Characterization of Mutant Mouse Strains Generated from the EUCOMM/KOMP-CSD ES Cell Resource. Mamm Genome 24: 286–294.

80. GustafssonE, BrakebuschC, HietanenK, FasslerR (2001) Tie-1-directed expression of Cre recombinase in endothelial cells of embryoid bodies and transgenic mice. J Cell Sci 114: 671–676.

81. TiedtR, SchomberT, Hao-ShenH, SkodaRC (2007) Pf4-Cre transgenic mice allow the generation of lineage-restricted gene knockouts for studying megakaryocyte and platelet function in vivo. Blood 109: 1503–1506.

82. PhamTH, BalukP, XuY, GrigorovaI, BankovichAJ, et al. (2010) Lymphatic endothelial cell sphingosine kinase activity is required for lymphocyte egress and lymphatic patterning. J Exp Med 207: 17–27.

83. HeinrichAC, PelandaR, KlingmullerU (2004) A mouse model for visualization and conditional mutations in the erythroid lineage. Blood 104: 659–666.

84. LivakKJ, SchmittgenTD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408.

85. InghamNJ, PearsonS, SteelKP (2011) Using the auditory brainstem response (ABR) to determine sensitivity of hearing in mutant mice. Current Protocols in Mouse Biology 1: 279–287.

86. Hunter-DuvarIM (1978) A technique for preparation of cochlear specimens for assessment with the scanning electron microscope. Acta Otolaryngol Suppl 351: 3–23.

87. MahajanVB, SkeieJM, AssefniaAH, MahajanM, TsangSH (2011) Mouse eye enucleation for remote high-throughput phenotyping. J Vis Exp 2011: pii: 3184.

88. WestH, RichardsonWD, FruttigerM (2005) Stabilization of the retinal vascular network by reciprocal feedback between blood vessels and astrocytes. Development 132: 1855–1862.